(Q46486654)

22 December 2017

title

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome (English)

1 reference

22 December 2017

1 reference

Eiske M Dorresteijn

1

1 reference

22 December 2017

Joana E Kist-van Holthe

2

1 reference

22 December 2017

Elena N Levtchenko

3

1 reference

22 December 2017

Jeroen Nauta

4

1 reference

22 December 2017

Wim C J Hop

5

1 reference

22 December 2017

Albert J van der Heijden

6

1 reference

22 December 2017

publication date

12 July 2008

1 reference

22 December 2017

published in

Pediatric Nephrology

1 reference

22 December 2017

volume

23

1 reference

22 December 2017

issue

11

1 reference

22 December 2017

page(s)

2013-2020

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s00467-008-0899-6

exact match

0 references

cites work

Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00467-008-0899-6

Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma

21 January 2018

1 reference

12 December 2020

Pharmacokinetics and tolerance of mycophenolate mofetil in renal transplant children

1 reference

12 December 2020

Mycophenolate mofetil in children with multidrug-resistant nephrotic syndrome.

1 reference

12 December 2020

Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation.

1 reference

12 December 2020

Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade

1 reference

12 December 2020

The long-term course of cyclosporine-associated chronic nephropathy

1 reference

12 December 2020

Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy

1 reference

12 December 2020

Reproducible erythroid aplasia caused by mycophenolate mofetil

1 reference

12 December 2020

Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children

1 reference

12 December 2020

Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil

1 reference

12 December 2020

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

1 reference

12 December 2020

Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis

1 reference

12 December 2020

Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.

1 reference

12 December 2020

Renal effects of cyclosporin A in children treated for idiopathic nephrotic syndrome

1 reference

12 December 2020

Value of therapeutic drug monitoring of MMF therapy in pediatric transplantation

1 reference

12 December 2020

Non-corticosteroid treatment for nephrotic syndrome in children

1 reference

12 December 2020

Cyclosporine in the treatment of idiopathic nephrosis

1 reference

12 December 2020

Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome

1 reference

12 December 2020

Nephrotic syndrome: from toddlers to twenties

1 reference

12 December 2020

Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome

1 reference

12 December 2020

Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children

1 reference

12 December 2020

Comparison between pre- and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis.

1 reference

12 December 2020

Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.

1 reference

12 December 2020

Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome

1 reference

12 December 2020

Estimation of the glomerular filtration rate in children: which algorithm should be used?

1 reference

12 December 2020

The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents

1 reference

12 December 2020

Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels

1 reference

12 December 2020

Switch from cyclosporine A to mycophenolate mofetil in nephrotic children

1 reference

12 December 2020

Effect of cyclosporin A on glomerular filtration rate in children with minimal change nephrotic syndrome

1 reference

12 December 2020

Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome

1 reference

12 December 2020

Limited sampling strategy for the determination of mycophenolic acid area under the curve in pediatric kidney recipients. German Study Group on MMF Therapy in Pediatric Renal Transplant Recipients

1 reference

12 December 2020

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome

1 reference

12 December 2020

A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children

1 reference

12 December 2020

10.1007/S00467-008-0899-6

Identifiers

DOI

1 reference

22 December 2017

PMC publication ID

7462920

0 references

1 reference

22 December 2017